Structural Adaptability Facilitates Histidine Heme Ligation in a Cytochrome P450 by McIntosh, John A. et al.
 S1 
 
 
 
 
Supporting Information: 
Structural adaptability facilitates histidine heme ligation in a 
cytochrome P450 
 
John A. McIntosh‡, Thomas Heel‡, Andrew R. Buller, Linda Chio, Frances H. Arnold* 
 
Division of Chemistry and Chemical Engineering, California Institute of Technology, 
1200 E. California Blvd, Pasadena, CA, 91125 
 
  *Correspondence addressed to frances@cheme.caltech.edu 
  ‡ These authors contributed equally 
 
 
 
 
 
 
 
 
 
 
 S2 
Table of content 
General S2 
Protein expression S2 
Protein purification S3 
Protein crystallography S4 
X-ray data collection and protein structure determination S4 
Thermostability measurements S5 
Spectral characterization S6 
Heme quantitation S6 
Supporting References S45 
 
General      
 All gene constructs were obtained from codon-optimized gBlocks® (IDT, San Diego, CA). 
Site-directed mutagenesis was accomplished by Quick-change-style mutagenesis using primers 
bearing desired mutations (IDT, San Diego, CA). Linear DNA was then cloned into pET22b cut 
with NdeI/XhoI restriction enzymes using Gibson cloning using the previously reported mixture of 
Taq ligase, T7 exonuclease, and Phusion polymerase.1 All enzymes used in cloning procedures 
were purchased from New England Biolabs. Primer and plasmid sequences available upon 
request. Hyper Broth™ was obtained from AthenaES™ and used according to manufacturer’s 
recommendations.  
 
Protein expression  
 CYP119 variants was expressed in BL21(DE3). Seed cultures of 2XYT-amp (50 mL, 100 
µg/mL ampicillin) were inoculated from glycerol stocks and grown overnight (200 RPM, 30 °C)  in 
Erlenmeyer flasks (125 mL capacity).  The resulting cultures were used to inoculate 1 L of Hyper 
Broth™ supplemented with ampicillin (100 µg/mL) in Fernbach flasks (2.8 L capacity). After 
inoculation, cultures were grown at 37 °C and 180 RPM for 3.5 hours, then cooled on ice for 10-
15 minutes and then induced via addition of IPTG (0.25 mM final concentration) and δ-
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aminolevulinic acid (0.5 mM final concentration).  Induced cultures were then grown overnight at 
reduced temperature and agitation rate (140 RPM, 25 °C). Following expression, cells were 
pelleted and frozen at -20 °C until purification.  
 
Protein purification 
 For purification, frozen cell pellets were resuspended (4 mL/g wet cell weight) in lysis 
buffer (25 mM tris, 100 mM NaCl, 30 mM imidazole, lysozyme (0.5 mg/mL), DNaseI (0.02 mg/mL), 
hemin  (1 mg/g wet cell weight), pH 7.5).  Cells were disrupted by sonication (3 min, output 
control 1.5, duty cycle: 1 sec on / 1 sec off; Sonicator 3000, Misonix, Inc.). The cell suspension 
was subsequently incubated for 30 min at 65 °C to precipitate E. coli proteins. To pellet insoluble 
cell debris, lysates were centrifuged (20,000 x g for 30 min at 4 °C). Cleared lysates were then 
loaded onto Ni-NTA columns (5 mL size, HP resin, GE Healthcare) using an AKTAxpress purifier 
FPLC system (GE healthcare). Target proteins were eluted using a linear gradient from 100% 
buffer A (25 mM tris-HCl, 100 mM NaCl, 10 mM, pH 7.5), 0% buffer B (25 mM tris, 100 mM NaCl, 
300 mM imidazole pH 7.5) to 100% buffer B over 10 column volumes.  
 Proteins used for crystallography were subjected to an additional ion-exchange 
purification step.  For these proteins, fractions were pooled, concentrated and exchanged into 
anion exchange buffer (25 mM tris-HCl buffer pH 7.5) and loaded onto an anion exchange Q 
Sepharose column (HiTrapTM Q HP, GE Healthcare) using an AKTAxpress purifier FPLC system 
(GE healthcare). The enzyme was eluted from the Q-column by running a gradient from 0 to 0.5 
M NaCl over 10 column volumes. Fractions containing the respective enzyme were pooled, 
concentrated and exchanged into storage buffer (25 mM tris, pH 7.5). Subsequently, the 
concentrated protein was aliquoted, flash-frozen on powdered dry ice, and stored at -80 °C. 
Enzyme concentrations were determined via molecular extinction coefficient from frozen aliquots. 
 Proteins used for other purposes were eluted from the Ni-NTA column as described 
above, and then pooled, concentrated to 1 mL, and subjected to three 10-fold dilution and 
concentration steps using centrifugal spin filters (Vivaspin 20, 30 kDA molecular weight cut-off, 
GE healthcare), each time diluting into fresh buffer (0.1 M KPi pH 8.0).   
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Protein crystallography 
CYP119 T213A/C317H was crystalized by vapor diffusion. A 1:1 mixture of protein stock 
(25 mg/ml enzyme in 50 mM KPi pH 8.0 I + 1 mM 4-phenylimidazole) and mother liquor was 
combined in 24-well sitting-drop plates (Hampton Research). The crystals were grown at room 
temperature over a span of 4–10 days. CYP119 T213A/C317H crystals formed in 0.1 M tris-HCl 
pH 7.25, 5 % PEG 4000.  
 
X-ray data collection and protein structure determination 
Crystals of T213A/C317H grew in 7 days and were cryoprotected with an additional 20 % 
glycerol before diffraction experiments at the Stanford Synchrotron Light Source. Despite 
extensive effort, only a single crystal was found to diffract to < 3.0 Å. Data indexed as spacegroup 
P21 and were integrated using XDS.2 Images were then scaled using AIMLESS to 2.7 Å 
resolution using a cutoff of CC1/2 > 0.3.3,4 
The structure was determined by molecular replacement using PHASER with the 4-
phenylimidazole-bound structure of CYP119 (PDB ID: 1F4T) with all ligands removed as the 
search model.5 From the output of this run, we identified and removed the ~110 residues of the 
initial model that had no density in the T213A/C317H structure. Molecular replacement was 
repeated with this trimmed model, which resulted in substantially improved initial maps. Model 
building was performed in Coot with iterative rounds of refinement in Refmac5.6,7 Each of the four 
molecules in the asymmetric unit were built independently due to significant structural differences. 
The register of the G and I helices was set using the unambiguous side chain density of the Gly-
Tyr residues at 173-174 and 201-202, respectively. The H-helix showed density extending 
towards two potential I-helices, one roughly matching the connectivity of the wild-type structure 
and the other suggesting domain-swapped dimerization had occurred. Using the side chain 
density at residues Gly201 and Tyr202 to accurately thread the I-helix, we found that the domain 
swapped dimer would be off register by two residues. We cannot assign the origin of the 
continuous electron density extending between these regions of the protein. Generally, chain C 
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had the best density and was used for subsequent analysis and to prepare the figures.    
Thermostability measurements 
Purified CYP119 variants (10 µM, 50 µL) were heated in a thermocycler (Eppendorf) over 
a range of temperatures (20 °C range, between 60 - 95 °C, e.g. 65 – 85 °C) for 10 min followed 
by rapid cooling to 4 °C for 1 min. The precipitate was removed by centrifugation. The 
concentration of folded CYP119 variant remaining in the supernatant was measured by CO-
difference spectroscopy as described elsewhere.8 Briefly, 40 µL of the heat-treated CYP119 
preparation was transferred to new wells in a microtiter plate. To this sample, dithionite solution 
(80 mM Na2S2O4 in 1 M KPi pH 8.0, 160 µL) was added. The absorbance from 390 to 490 nm 
was recorded using a Tecan M1000 UV/Vis plate reader in 2 nm steps, and the microtiter plates 
were placed in a vacuum chamber. The chamber was sealed, evacuated to approximately -30 in 
Hg, purged with CO gas, and incubated for 30 min. The plates were then removed and the 
absorbance from 390 to 490 nm was again recorded using the plate reader. The difference 
spectra were taken by subtracting the absorbance at each wavelength before exposure from the 
absorbance of the ferrous CO-treated samples (i.e. ferrous CO bound absorbance minus ferrous 
absorbance). Baselines were normalized by subtracting the absorbance at 490 nm from the Soret 
maximum in both starting spectra and ferrous CO-bound spectra. Variants C317S, C317T, 
C317G, and C317P underwent shifts in their ferrous-CO difference spectra upon heating, and 
thus for these variants the lowest heated condition (which is lower than the 65 oC heat-treatment 
used during lysis) was used to normalize the other Soret signals to determine the fraction of 
folded enzymes remaining. The observed Soret shifts may reflect the higher protein concentration 
used for T50 assays (as opposed to lysate), and thus may reflect an aggregation behavior. The 
temperature at which half of the protein was denatured (T50) was determined by fitting the data to 
the equation: f (T) = 1 / (1 + exp ((T50-T)/C) + C2. 
 
Spectral characterization 
Proteins used in spectral characterization were thawed and then subjected to three 
additional concentration and dilution steps.  Concentrations were then determined by the 
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pyridine-hemochrome assay described above, and then proteins were diluted to 10 µM final 
concentration and analyzed by UV-visible spectroscopy from 350-600 nm in a plastic cuvette.  To 
reduce enzymes, solid dithionite was added, and the cuvette was covered with parafilm and then 
read.  After a satisfactory reduced spectrum was obtained, samples were bubbled with carbon 
monoxide for ~ 30s, or until a clear spectral shift was observed. Spectra were then exported to 
excel and analyzed.   
 
Heme quantitation 
Holoprotein concentrations were determined on the basis of their heme content, which 
was determined using the pyridine-hemochrome assay.  The assay was performed according to 
established methods.9 Briefly, a protein sample (5-20 µL) was added to a cuvette, along with 2 µL 
of 0.1 M K3Fe(CN)6 and pyridine-hemochrome reagent solution (80% water, 20 % pyridine (v/v), 
50 mM NaOH).  After mixing, 3-5 mg of solid dithionite was added, the cuvette was covered with 
parafilm and gently flicked to dissolve dithionite.  Samples were read immediately and the 
absorbance spectrum scanned between 600 and 400 nm.  The peak absorbance at 418 nm was 
used to determine concentration using the published extinction coefficient of 191,500 M-1 cm-1.9  
 Relative heme loadings were determined by the following procedure.  Enzymes were 
diluted to 10 µM.  A portion of the enzyme solution (100 µL in 0.1 M KPi pH 8.0) was mixed with 
formic acid solution (5 % v/v, 400 µL) to denature the protein and release the heme.  To correct 
for pipetting and dilution errors, some samples were diluted more at this stage via addition of 
buffer (4:1 5% v/v formic acid: 0.1 M KPi pH 8.0) such that the heme absorbance (A395) was 
between 0.13 and 0.15.  At this point the protein absorbance peak at 276 nm and the 395 nm 
absorbance were measured.  The ratio of the heme content to the protein content was then used 
to determine a rank order of heme loadings among different axial variants.   
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Table S1.  Crystallographic data collection and refinement statistics 
Variant  T213A/C317H    
Space group  P21    
Cell dimensions (Å) a,b,c =  64.5, 137.9, 91.8   
Cell angles α = γ = 90°, β = 101.18°   
Data Collection       
Wavelength (Å)  0.9795 
 
  
Beamline  SSRL 12.2 
 
  
Resolution (Å)  50 - 2.7 
 
  
Last Bin (Å)  2.7 - 2.8 
 
  
No. Observations  138,213 
 
  
Completeness (%)  98.5 (97.6) 
 
  
Rpim (%)  0.051 (0.499) 
 
  
CC(1/2)  0.995 (0.565) 
 
  
I/σI  10.7 (1.6) 
 
  
Redundancy  3.3 (3.1) 
 
  
      
Refinement      
Total no. of reflections  40139  
 
 
Total no. of atoms  9827    
No. of waters      
Final bin (Å)  2.7 - 2.77    
Rwork (%)  23.8 (35.0)    
Rfree (%)  27.7 (38.1)    
Average B factor (Å2)  64.5    
Ramachandran plot allowed, %  97.7    
Favored, %  99.9    
Outliers, %   0.1    
Values in parenthesis are for the highest resolution shell 
   Rmerge is Σ|Io – I| / ΣIo , where Io is the intensity of an individual reflection, and I is the 
mean intensity for multiply recorded reflections 
   Rwork is ||Fo – Fc|| / Fo, where Fo is an observed amplitude and Fc a calculated amplitude; 
Rfree is the same statistic calculated over a 5% subset of the data that has not been 
included during refinement. 
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Table S2.  Summary of UV-visible spectroscopy of C317X mutants.  Broad peaks 
marked ‘br’. 
 
λ (nm) 
 
α β Soret 
WT Fe(III) 568 536 417 
WT Fe(II)CO 548 (br) 548 (br) 449 
    T213A/C317H Fe(III) - 532 (br) 409 
T213A/C317H Fe(II) 559 - 428 
T213A/C317H Fe(II)CO 568 538 422 
    C317H Fe(III) - 528 (br) 409 
C317H Fe(II) 559 (br) - 428 
C317H Fe(II)CO 569 540 422 
    C317G Fe(III) 578 544 413 
C317G Fe(II) 551 - 426 
C317G Fe(II)CO 568 540 414 
    C317A Fe(III) 570 - 405 
C317A Fe(II) 551 - 424 
C317A Fe(II)CO 553 - 400 
    C317S Fe(III) - - 404 
C317S Fe(II) 550 (br) 550 (br) 422 
C317S Fe(II)CO 564 528 408 
    C317T Fe(III) 575 (br) 524 (br) 408 
C317T Fe(II)CO 574 536 413 
    C317P Fe(III) - 529 411 
C317P Fe(II) 560 531 427 
C317P Fe(II)CO 567 540 423 
    C317V Fe(III) - 532 408 
C317V Fe(II) 558 (br) 558 (br) 429 
C317V Fe(II)CO 567 539 422 
    C317L Fe(III) - 527 409 
C317L Fe(II) 559 535 427 
C317L Fe(II)CO 567 539 422 
    C317I Fe(III) - 525 (br) 409 
C317I Fe(II) 559 559 (br) 427 
C317I Fe(II)CO 568 539 422 
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λ (nm) 
 
α β Soret 
C317M Fe(III) - 528 408 
C317M Fe(II) 559 530 427 
C317M Fe(II)CO 569 540 422 
    C317N Fe(III) - 530 411 
C317N Fe(II) 561 (br) 561 (br) 428 
C317N Fe(II)CO 568 539 422 
    C317D Fe(III) - 531 408 
C317D Fe(II) 560 (br) 560 (br) 427 
C317D Fe(II)CO 570 539 422 
    C317Q Fe(III) - 526 (br) 408 
C317Q Fe(II) 558 (br) 558 (br) 428 
C317Q Fe(II)CO 567 540 422 
    C317E Fe(III) - 530 411 
C317E Fe(II) 560 (br) 560 (br) 427 
C317E Fe(II)CO 569 540 423 
    C317K Fe(III) - 530 410 
C317K Fe(II) 559.5 (br) 559.5 (br) 427 
C317K Fe(II)CO 569 540 422 
    C317R Fe(III) - 532 411 
C317R Fe(II) 559 (br) 559 (br) 427 
C317R Fe(II)CO 569 540 422 
    C317F Fe(III) - 528 409 
C317F Fe(II) 558 (br) 558 (br) 428 
C317F Fe(II)CO 567 539 422 
    C317Y Fe(III) - 526 408 
C317Y Fe(II) 558 (br) 558 (br) 428 
C317Y Fe(II)CO 567 540 422 
    C317W Fe(III) - 529 408 
C317W Fe(II) 558 (br) 558 (br) 428 
C317W Fe(II)CO 568 540 422 
 
 
 
 
 
 S10 
 
 
 
Figure S1.  UV-visible spectra for C317X variants 
Ferric, ferrous, and ferrous CO spectra are shown as dotted, double-line, and solid line 
traces.  Wild-type and C317T variants could not be completely reduced under semi-
aerobic conditions, and thus ferrous spectra are not shown.  
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Table S3.  Relative heme incorporation levels for C317X mutants   
Higher heme loading is reflected in increased ratios of 395 nm to 276 nm absorbances 
for the acid-denatured proteins.   
C317X A395/A276 ratio 
Arg 1.5 
Lys 1.5 
His 1.4 
Glu 1.4 
Leu 1.4 
Trp 1.3 
Met 1.3 
Ile 1.3 
Tyr 1.3 
Cys (T213A) 1.2 
Gln 1.2 
Pro 1.2 
His (T213A) 1.2 
Asp 1.2 
Phe 1.1 
Cys (WT) 1.1 
Val 1.1 
Gly 1.0 
Ala 1.0 
Asn 1.0 
Thr 0.9 
Ser 0.8 
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Table S4.  T50 data for axial mutants described in this study.  Axial mutants 
are ordered from highest to lowest T50 (the temperature at which half of the 
protein is unfolded after a ten minute incubation – see Methods for complete 
assay description).  Additional mutations shown in parentheses. 
 
C317X T50 (°C) 
Cys (T213A) 85.7 
Cys (WT) 84.6 
His (T213A) 83.4 
Lys 79.6 
Gly* 79.3 
Glu 79.2 
Gln 79.2 
Arg 79.1 
Tyr 79.1 
Thr* 79.1 
Leu 78.9 
Trp 78.8 
Val 78.8 
Asp 78.6 
Asn 78.5 
His 78.5 
Ile 78.3 
Pro* 78.2 
Met 78.1 
Phe 78.1 
Ser* 77.9 
Ala 77.1 
*Underwent Soret shift upon 
heating 
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Figure S2. C317X T50 curves and raw spectral data (shown in difference mode) used to 
generate T50 curves.  Variants C317G, C317S, C317T, C317P gave shifts in their CO-
bound Soret difference maxima upon heating, and thus for these the lowest-heated 
condition was used to normalize the other ferrous CO-bound Soret signals.  The 
differences in these variants could be traced to overt shifts in either the ferric or ferrous-
CO Soret peaks.   
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